Search for: "APP Pharmaceuticals, Inc." Results 221 - 240 of 414
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Apr 2012, 1:46 pm
Here are a few we have blogged about: Eli Lilly and Company Sues Accord Healthcare for Patent Infringement of Lung Cancer Drug ALIMTA Eli Lilly Company Sues APP Pharmaceuticals LLC for Patent Infringement of Chemotherapy Drug Lilly Wins Patent Infringement Suit Regarding Chemotherapy Drug [read post]
18 Apr 2012, 1:29 pm by Bexis
Janssen Pharmaceuticals, Inc., 951 N.E.2d 1238 (Ill. [read post]
29 Mar 2012, 9:55 am by Bexis
Premo Pharmaceutical Laboratories Inc., ___ N.Y.S.2d ___, 2012 WL 914997 (N.Y. [read post]
3 Mar 2012, 5:36 pm by Schachtman
(El Paso Cty., Tex. 2002) Pharmaceutical Cases Ambrosini v. [read post]
29 Feb 2012, 8:25 am by Schachtman
Pharmaceutical cases that warrant federal court multi-district litigation (MDL) treatment typically involve complex scientific and statistical issues. [read post]
22 Feb 2012, 4:40 am by Rob Robinson
 bit.ly/yRWkxa (Henry Kelston) How to Create an eDiscovery Team – An Interview with HB Gordan from Teva Pharmaceuticals – bit.ly/xCM6yj (Amber Scorah) How to Reduce Medical Malpractice eDiscovery Issues and Costs - bit.ly/ylZmA5 (Matthew Keris) Innovation and Informed Risk-Taking are an eDiscovery Duty - bit.ly/zKtiDm (Chris Dale) Lester v. [read post]
2 Feb 2012, 4:21 am by Max Kennerly, Esq.
Komen Breast Cancer Foundation, Inc., cut all grant funding for Planned Parenthood Federation of America, Inc. [read post]
31 Jan 2012, 6:13 am by Bexis
  Joe represents one of the successful moving defendants in the very recent decision that's described below.Take it away Joe:*****************On January 30, 2012, the United States District Court for the Eastern District of New York granted summary judgment in favor of Sandoz Inc., APP Pharmaceuticals, Inc., Ben Venue Laboratories, Inc., Teva Parenteral Medicines, Inc., and Hospira, Inc. with respect to all remaining plaintiffs… [read post]
12 Jan 2012, 1:15 pm by Bexis
“[W]e are troubled by the lack of uniformity and certainty inherent in the case-by-case approach and fear the resulting disincentive for pharmaceutical manufacturers to develop new products. [read post]
26 Dec 2011, 1:02 am by Victoria VanBuren
Ortho-McNeil-Janssen Pharmaceuticals, Inc. , No. 11-2070 (7th Cir. [read post]